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Background: Antimicrobial peptides have become important candidates as new antibiotics against resistant
bacterial strains. However, the major industrial manufacture of antimicrobial peptides is chemical synthesis with
high costs and in relatively small scale. The Ub-tag and SUMO-tag are useful for increasing the yield of enzymes
and other proteins in expression system. In this study, antimicrobial peptide A20L (KWKSFLKTFKSAKKTVLHTLLKAISS),
a derivative of V13K in the previous study is used as a template to be expressed in different Ub-tag and human
SUMO tag systems to compare the prokaryotic expression approaches of antimicrobial peptide. The antibacterial
mechanism of action and membrane specificity of A20L was further studied.
Methods: We fused the Ub and SUMO1/2/3/4 with A20L to construct expression plasmids. Ub-A20L and SUMO1/2/34
gene sequences were inserted into the pHUE plasmids and pET-28b+ plasmids, respectively, to construct pHUE-A20L
plasmids and pET-28b+-SUMO1/2/3/4-A20L plasmids. These plasmids were transformed into E. coli Rosetta (DE3) and
induced with IPTG to express Ub-A20L and SUMO1/2/3/4 fusion proteins. The recombinant proteins were found in the
soluble fraction after being over expressed in E. coli Rosetta (DE3). Antibacterial and hemolytic activities and membrane
permeabilization ability of A20L were determined. Peptide structure was also studied by circular dichroism experiments.
Results: A20L (KWKSFLKTFKSAKKTVLHTLLKAISS) was successfully expressed by fusion with an ubiquitin tag (Ub-tag)
and human SUMO tags (SUMO1/2/3/4-tags). A20L exhibited antimicrobial activity against various Gram-negative and
Gram-positive bacteria. Based on the hemolytic activity against human red blood cells, A20L showed good specificity
against bacteria. The circular dichroism experiments illustrated that A20L was transferred into an α-helical structure in
the presence of hydrophobic environment. The antibacterial mechanism of action and membrane specificity of A20L
was further studied using membrane permeabilization experiments and tryptophan fluorescence and quenching
experiments in liposomes.
Conclusions: The Ub-tag and human SUMO-tags represent good alternatives to chemical synthesis for the industrial
production of antimicrobial peptides with low costs and high yields. The antibacterial mechanism of action of A20L
was proved as membrane disruption. A20L showed stronger specificity on liposomes mimicking bacterial membrane
than those mimicking eukaryotic cell membrane, which is consistent with the biological activity studies.
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Bacteria are developing resistance to antibiotics at an
alarming rate, thus the development of new antibiotic
alternatives continues to be extremely urgent [1, 2]. Be-
cause of their antibacterial properties, antimicrobial
peptides (AMPs) are expected to become ideal anti-
biotic alternatives [3]. AMPs are generally between 10
and 50 amino acid residues, and are strongly cationic
(pI 8.9–10.7) [4]. AMPs are characterized by their
broad spectrum of activities and their antibacterial
mechanism differs from traditional antibiotics [5]. To
date, there are more than 2000 types of AMPs that have
been isolated, including some that have been used in
the health care and food processing industries [6, 7].
AMPs are primarily harvested via natural extraction,
chemical synthesis and genetic engineering. The large-
scale application of AMPs is restricted by limitations in
sourcing the natural products and the high production
costs of chemical synthesis. A prokaryotic expression
system can reduce the production cost of AMPs and
increase their large-scale applications [8]. However, pro-
karyotic expression of AMPs is technically challenging
because AMPs are not only toxic to the host, but also
susceptible to exogenous protease degradation. Previous
studies have shown that use of a fusion tag system can
achieve effective expression of AMPs [9]. Fusion tags
commonly used include thioredoxin, steroid isomerase
and glutathione-S-transferase enzymes. However new fu-
sion tags useful to improve the yield of AMPs are con-
tinuously coming out.
Ubiquitin (Ub) has 76 amino acids and mainly func-
tions to label proteins for hydrolysis [10]. Small
ubiquitin-related modifier (SUMO) consists of about
100 amino acid residues, and modulates protein struc-
ture and function by covalent modification of target pro-
teins in eukaryotes. Yeast cells have only one SUMO gene
(SMT3), while there are four SUMO genes in vertebrates,
SUMO1, SUMO2, SUMO3, SUMO4 [11]. Recent studies
have shown that Ub and SUMO were used as fusion tags.
Their small sizes bring relatively high peptide-to-carrier
ratios, favors the increase of yield in the production of
antimicrobial peptides. The highly specific sumoase
facilitates efficient release of the antimicrobial peptide
[12]. In previous studies, we obtained the AMP A20L
(KWKSFLKTFKSAKKTVLHTLLKAISS, 2991.6 Da) [13],
which is a derivative of the V13K in which the amino acid
alanine in position 20 was substituted by leucine, and
showed that it possesses good antimicrobial activity and
low hemolytic activity. In this study, we used the Ub-tag
and human SUMO1/2/3/4-tag fusion to express A20L
in a prokaryotic system and further explore the antibac-
terial mechanism of action of AMPs with membrane
permeabilization experiments, tryptophan fluorescence
and quenching experiments in liposomes.Methods
Materials
Escherichia coli (E. coli) strain DH5α, Rosetta (DE3) and
the expression plasmid pET-28b + were purchased from
Novagen Co. Ltd. (Darmstadt, Germany). Sumoase and
pHUE were gifts from Prof. Xuexun Fang, Jilin University,
China. The plasmid pHUE was constructed for the ex-
pression of His-tagged ubiquitin (Ub) fusion proteins by
modifying pET15b. It contains the inducible T7 RNA
polymerase promoter, a histidine tag at the 5′ end of an
ubiquitin open reading frame and an extended polylinker
[14]. pUC57-SUMO1/2/3/4-A20L and pUC57-A20L
plasmids were constructed by Genewiz Co. Ltd.
(Suzhou, China). E. coli ATCC25922, Pseudomonas aeru-
ginosa (P. aeruginosa) ATCC27853, Staphylococcus aureus
(S. aureus) ATCC25923, Bacillus subtilis (B. subtilis)
ATCC6633 and E. coli ML-35 ATCC 43827 were pur-
chased from the American Type Culture Collection
(USA). Restriction endonucleases NdeI, BamHI and EcoRI
were purchased from Takara Biotech Co. Ltd. (Dalian,
China). The bicinchoninic acid (BCA) protein assay kit
was purchased from Shanghai Biological Engineering Co.,
Ltd., China. Luria-Bertani (LB) medium and Mueller-
Hinton (MH) medium were purchased from Dingguo Co.
Ltd. (Beijing, China). CM Sepharose FF chromatog-
raphy medium was purchased from GE Chemical Co.
(Uppsala,USA), and Ni-NTA chromatography medium
was purchased from Qiagen Co. Ltd. (Hilden, Germany).
Prestained SDS-PAGE standards were purchased from
Transgen Co. Ltd. (Beijing, China). Trifluoroethanol
(TFE), 1-N-phenylnaphthylamine (NPN), o-nitrophenyl-β-
D-galactoside (ONPG) and phenylmethanesulfonyl fluoride
(PMSF) were purchased from Sigma (Beijing, China).
L-α-phosphatidyl-dl-glycerol (PG), L-α-phosphatidylcholine
(PC) and cholesterol were purchased from Avanti Polar
Lipids, Inc. (Alabama, USA). HEPES and KI were pur-
chased from Beijing Chemical Works (Beijing, China).Plasmid construction
The pUC57-SUMO1/2/3/4-A20L and pUC57-A20L plas-
mids were served as templates. The A20L gene sequence
(AAATGGAAATCTTTCCTGAAAACCTTCAAATCTG
CTAAAAAAACCGTTCTGCACACCCTGCTGAAAGC
TATCTCTTCT) was amplified by PCR (Additional file 1:
Table S1 and Table S2). The PCR product of the A20L
and pHUE plasmid was doubly digested by BamHI and
EcoRI. The PCR products of SUMO1/2/3/4-A20L and the
pET-28b + plasmid were doubly digested with NdeI and
EcoRI. After digestion, T4 DNA Ligase was used to link
and transform E. coli DH5α competent cells, and then
monoclonal colonies were inoculated in LB culture
medium for plasmid sequencing. The plasmid construc-
tion process is shown in Fig. 1.
Fig. 1 The cloning and cleavage strategy for Ub-A20L and SUMO1/2/3/4-A20L. (a) pHUE-A20L, which was constructed by inserting the A20L gene
at the BamHI/EcoRI sites of pHUE; (b) pET28b + −SUMO1/2/3/4-A20L, which was constructed by inserting the A20L gene at the BamHI/EcoRI sites
of pET-28b+; (c) the cleavage strategy for Ub-A20L and SUMO-A20L
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The pET-28b + −SUMO1/2/3/4-A20L and pHUE-A20L
plasmids were transformed into E. coli Rosetta (DE3)
competent cells. Single colonies were picked, shaken and
cultured at 37 °C and 180 rpm for 16 h. Then, the bac-
terial suspension at a volume ratio of 1:100 was cultured
in LB medium, shaken at 37 °C, 180 rpm for 3 h until
the OD600 nm was 0.4–0.6. Isopropyl β-D-1-thiogalacto-
pyranoside (IPTG) at a final concentration of 1 mM was
added to induce expression at 32 °C and 180 rpm for
4 h followed by centrifugation (6000 × g for 10 min).
After addition of Buffer A (50 mM Na2HPO4/NaH2PO4,
300 mM NaCl, 1 mM phenylmethanesulfonyl fluoride,
pH 7.4), the samples were sonicated (200 W, 10 min)
and centrifuged to collect the supernatant. A 2 mL Ni-
NTA column was washed and equilibrated with Buffer B
(50 mM Na2HPO4/NaH2PO4, 300 mM NaCl, pH 7.4)
and then the supernatant was cycled over the Ni-
NTA column for 1 h. After rinsing with Buffer B and
10 mL Buffer C (50 mM Na2HPO4/NaH2PO4, 300 mM
NaCl, 50 mM imidazole, pH 7.4), 10 mL Buffer D
(50 mM Na2HPO4/NaH2PO4, 300 mM NaCl, 300 mMimidazole, pH 7.4) was used to elute the target pro-
teins, Ub-A20L and SUMO1/2/3/4-A20L. Target pro-
teins were dialyzed against 500 mL Buffer E (20 mM
Na2HPO4/NaH2PO4, pH 8.4) overnight. A 10 mL CM
Sepharose FF column was first equilibrated with Buf-
fer E, and loaded with the target proteins for 1 h,
followed by purification with Buffer F (20 mM
Na2HPO4/NaH2PO4, 0.1–1 M NaCl, pH 8.4) to yield
Ub-A20L and SUMO1/2/3/4-A20L. The purity of the
target proteins was assessed using 12 % SDS-PAGE
electrophoresis. The fused proteins were combined
with sumoase at a molar ratio of 1:50 and digested
overnight at 4 °C. After digestion, a Sephadex G25
column (2 cm × 80 cm) was employed for separation
purpose. Buffer G (20 mM Na2HPO4/NaH2PO4,
pH 7.4) was used as an eluent to purify A20L. Tricine
SDS-PAGE electrophoresis analysis was used to check
the purity of A20L, and the polypeptide yield was deter-
mined using the Walker method [15]. The concentra-
tions of A20L were calculated in the equation: A20L (in
μg/ml) = 144 × (OD215nm- OD225nm). The experiments
were separately performed six times.
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The minimal inhibitory concentration (MIC) of A20L was
determined using the broth dilution method [16]. A single
bacterial colony was picked and cultured at 37 °C, 180 rpm
for overnight. Wells of a 96-well plates were filled with 90 μL
of the bacterial suspension (5 × 105 CFU/mL in MH media)
and 10 μL of of serial two fold dilutions of the A20L peptide
(stock concentration 2 mg/mL) and cultured at 37 °C and
170 rpm, for 24 h. The OD590 nm was determined to calcu-
late the MIC. The experiments were performed in triplicates.
Hemolytic activity determination
The A20L peptides were doubly diluted at an initial con-
centration of 2 mg/mL and added to 96-well plates at a
density of 70 μL per well. Healthy human blood (1–2 mL)
from healthy volunteers was centrifuged at 1000 × g for
5 min and washed thrice with PBS. Erythrocytes were re-
suspended and counted, and diluted to a concentration of
2 × 108 cells/mL. The diluted erythrocytes were added to
96-well plates at a density of 70 μL per well and mixed with
A20L, incubated at 37 °C for 2 h, and centrifuged at 3000 ×
g for 10 min. The release of hemoglobin was determined
by measuring the optical density of the supernatant at
OD578 nm. The hemolytic activity was measured as the min-
imal hemolytic concentration (MHC). PBS containing 1 %
erythrocytes and distilled water were used as a negative
control and 100 % hemolysis positive control [16], respect-
ively. The experiments were performed in triplicates.
Circular dichroism experiments
The secondary structures of the A20L peptide at a con-
centration of 75 μM were determined using a Jasco J-810
circular dichroism spectrometer (Jasco, Easton, MD) at
25 °C in non-denaturating buffer (100 mM KCl, 50 mM
KH2PO4/K2HPO4, pH 7.0) or in the presence of α-helix
inducing 50 % 2,2,2-trifluoroethanol (TFE) (non-dena-
turating buffer:TFE = 1:1, vol/vol). The A20L second-
ary structure was confirmed by calculating the
average molar ellipticity at 222 nm ([θ]222) [17]. The
experiments were separately performed three times.
Outer membrane permeabilization experiments
The change of outer membrane permeability in bacteria
after interaction with A20L was analyzed using the
hydrophobic fluorescent probe 1-N-phenylnaphthylamine
(NPN). P. aeruginosa was inoculated in 20 mL LB liquid
medium, shaken and cultured at 37 °C for 18 h. A 1 mL
bacterial suspension was inoculated into 50 mL of LB
medium, shaken and cultured at 37 °C until the OD600 nm
was 0.4–0.6. After centrifugation (4000 × g for 10 min),
bacteria were collected and resuspended in buffer (5 mM
HEPES, 5 mM NaN3, 0.25 mM NPN, pH 7.4) to OD600
nm = 0.5 which equated to 300 μL of a 800 μg/mL A20L
solution added to 2.7 mL of bacterial suspension. Anegative control was prepared in the same volume of reac-
tion buffer (5 mM HEPES, 5 mM NaN3, pH 7.4). A Shi-
madzu RF-5301 PC spectrofluorophotometer (excitation
wavelength 350 nm, emission wavelength 420 nm) was
used to continuously collect data for 10 min [18]. The ex-
periments were separately performed ten times.
Inner membrane permeabilization experiments
Permeabilization of the inner membrane was assessed by
measuring the access of ο-nitrophenyl β-D-galactopyranoside
(ONPG) to the cytoplasm. We used the permease-deficient
strain E. coli ML-35, which constitutively expresses
cytoplasmic β-galactosidase. E. coli ML-35 was cultured
in LB medium containing 5 % lactose. The bacterial
cells were collected and resuspended with sterile water
to an OD420nm of 1.2. A total of 1000 μL of bacterial
suspension was mixed with 100 μL of 30 mM o-
nitrophenyl-β-D-galactosidase (ONPG), and then added
to 900 μL of 16 μg/mL A20L. The negative control was
carried out with 0.5 % NaCl. A Shimadzu UV-2550 UV
spectrophotometer (wavelength set to 420 nm) was
used to continuously collect data for 90 min [19].
Tryptophan fluorescence and quenching experiments
As reported previously, the liposomes were prepared and
cultured in HEPES buffer (pH 7.4, 10 mM HEPES,
150 mM NaCl) such that their molar concentration was ad-
justed to 100 μM [20]. A total of 14 μL of 100 μM A20L
and 686 μL of 100 μM liposomes were combined together
at 25 °C for 10 min. A Shimadzu RF-5301 PC, (excitation
wavelength: 350 nm, emission wavelength of 300–450 nm)
was used to measure the tryptophan fluorescence [20]. Po-
tassium iodide (KI) at a final concentration of 0.02–0.08 M
was added to the reaction system and the tryptophan fluor-
escence was measured as described above. The Stern-
Volmer equation was used to calculate the quenching
constant Ksv. The experiments were performed in triplicates.
Ethics and consent statements
Research involving human subjects that is reported in
the manuscript has been performed with the approval of
the ethics committee of School of Life Sciences, Jilin
University, China (Reference No. JSK-RTLL2014003).
Research carried out on humans is in compliance with
the Helsinki Declaration. The written informed consent
for the participant who supplies human red blood cells
in this study was obtained from the participant.
Results
Expression, purification and digestion of Ub-A20L and
SUMO1/2/3/4-A20L
To explore the function of Ub protein and SUMO1/2/3/
4 proteins as fusion tags, we fused the Ub and SUMO1/
2/3/4 with A20L to construct expression plasmids. Ub-
Fig. 2 (a) Expression of A20L fused with Ub, SUMO1, SUMO2, SUMO3 and SUMO4 proteins. (M): molecular weight marker; (UN): un-induced
culture; (IN): induced culture; (Ni): Ni-NTA purified pool; (b) purification of Ub-A20Land SUMO1/2/3/4-A20L by CM Sepharose FF. (M): molecular
weight marker; (1) Ub-A20L; (2) SUMO1-A20L; (3) SUMO2-A20L; (4) SUMO3-A20L; (5) SUMO4-A20L; (c) purification of A20L (M): molecular weight
marker; (1–5): A20L purified from Ub-A20L(1),SUMO1-A20L(2),SUMO2-A20L(3), SUMO3-A20L(4),SUMO4-A20L(5)
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into the pHUE plasmids and pET-28b + plasmids, re-
spectively, to construct pHUE-A20L plasmids and pET-
28b + −SUMO1/2/3/4-A20L plasmids. These plasmids
were transformed into E. coli Rosetta (DE3) and induced
with IPTG to express Ub-A20L and SUMO1/2/3/4 fusion
proteins. The recombinant proteins were found in the sol-
uble fraction after being over expressed in E. coli Rosetta
(DE3). Their relative expression levels were calculated byTable 1 Purification of A20L from E. coli Rosetta (DE3) cells expressin






aThe quantity of target protein was estimated by SDS gel scanning
bThe quantity of target protein was determined by the BCA method
cThe quantity of A20L was determined by the Walker method [15]gel scanning (Fig. 2a and b). The yield of the protein
expression was 76.3 mg/L and 51.5–21.9 mg/L for Ub-
A20L and SUMO1/2/3/4, respectively (Fig. 2a; Table 1).
After cell disruption, the supernatant was obtained and
purified using Ni-NTA affinity chromatography and CM
Sepharose FF cation exchange chromatography. The
peptide purity was determined by 12 % SDS-PAGE, and
the protein yield was determined by the BCA method.
The yield of Ub-A20L and SUMO1/2/3/4-A20L wasg Ub-A20L and SUMO1/2/3/4-A20L in a batch culture of 1 L
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Table 1). After sumoase cleavage, the A20L peptide was ob-
tained from Sephadex G25 column purification. The yield of
the A20L peptide was 7.3 mg/L from Ub-A20L and 2.0–
5.4 mg/L from SUMO1/2/3/4-A20L after enzyme digestion
(Fig. 2c and Table 1). This indicates that both Ub and
SUMO1/2/3/4 tags are able to promote the expression of the
A20L peptide, but Ub-tag was effective than SUMO1/2/3/4.
Antibacterial and hemolytic activities
The geometric mean (GM) of the MIC values for the
four microbial strains was calculated as an overall indi-
cator of the antibacterial activity of the AMP. A20L ex-
hibited strong antimicrobial activity against various
Gram-negative and Gram-positive bacteria. The MIC
values for Gram-negative and Gram-positive bacteria
were 2.67–21.33 μg/mL, and the GM value was calcu-
lated to be 6.87 μg/mL, (Table 2). The MHC value of the
peptide against human erythrocytes was determined to
represent peptide toxicity. A20L showed negligible
hemolytic activity against human red blood cells
(213.33 μg/mL). The therapeutic index (TI) is a widely
used parameter indicating the specificity of AMPs, and
is expressed as the ratio of MHC/MIC. In this study, the
TI was 31.05, indicating that the A20L peptide has high
antibacterial specificity (Table 2).
Peptide secondary structure
The helicity is a biophysical parameter closely related to
the antibacterial activity [20]. In this study, we studied the
variation in the secondary structure of the A20L peptide
by measuring its circular dichroism spectrum under dif-
ferent buffer systems. The results showed that the [θ] 222
of A20L in the non-denaturating buffer was −4363 degree
• cm2• dmol−1, indicating that the structure of A20L is
disordered, while the [θ] 222 of the peptide was −33424
degree•cm2•dmol−1 in the presence of 50 % TFE to mimic
the hydrophobic environment, indicating that the peptide
formed a typical α-helical structure under hydrophobic
environments such as biomembranes (Fig. 3).
Membrane permeabilization
Gram-negative bacterial cell membranes are divided into
outer and inner membranes, whilst, Gram-positive
bacteria only have cytoplasmic membranes, which areTable 2 Antimicrobial (MIC) and hemolytic (MHC) activities of A20L
Peptide MIC
(μg/ml)
Escherichia Coli Pseudomonas aeruginosa Staphylo
ATCC25922 ATCC27853 ATCC259
A20L 2.67 7.33 21.33
aGM denotes the geometric mean of the MIC values from all four microbial strains
bTherapeutic index (TI) = MHC (μg/ml)/geometric mean of MIC (μg/ml)composed of similar lipid components as the inner
membranes of Gram-negative bacteria. Pseudomonas
aeruginosa and Escherichia coli ML-35 were selected for
the outer membrane and inner membrane assays,
respectively, since Pseudomonas aeruginosa is a most
common infectious bacterium in clinics and Escherichia
coli ML-35 is a lactose permease-deficient strain. AMPs
provoke the disruption of the bacterial membrane to kill
the bacteria. After A20L interacts with bacteria, changes
in the outer membrane permeability can be detected
using the fluorescence probe NPN. The fluorescence
intensity emitted from NPN is weak in a hydrophilic en-
vironment, but very strong in a hydrophobic environment
such as the hydrophobic core of a bacterial cell membrane
[18]. In the outer membrane permeabilization experiment,
after the interaction of A20L with bacteria, NPN was
deeply inserted into the core of hydrophobic region within
2 min, and the fluorescence intensity was observed to in-
crease from 50 to 650 (Fig. 4a).
β-Galactosidase is located in the bacterial cytoplasm,
and can hydrolyze ONPG into galactose and o-nitrophe-
nol which shows yellow color. In untreated E. coli,
ONPG is transferred into the cytoplasm via lactose per-
mease, while if inner membrane destruction has occurred,
ONPG can rapidly enter into the bacteria to react with β-
galactosidase. By measuring the change in OD420 nm, we
could determine whether or not ONPG was able to pene-
trate the cytoplasm, thus indicating whether the bacterial
inner membrane is damaged [19]. The intracellular release
of β-galactosidase became stable after 10 min and the
OD420 nm increased from 0.6 to 1.4 (Fig. 4b). Outer and
inner membrane permeabilization assays indicate that the
A20L peptide exhibited destructive effects on both bac-
teria membranes. Additionally, there was a clear distinc-
tion between the penetration time of A20L into the outer
and inner bacterial membranes. As expected, A20L first
damaged the outer membranes, then the inner mem-
branes were also damaged subsequently.
Interaction of A20L with liposomes
In this study, tryptophan fluorescence and quenching
experiments were carried out to study the insertion of
A20L into different types of membrane structures. Tryp-
tophan fluorescence Intensity is increased in a hydro-
phobic environment, and the blue shift occurred at theMHC
(μg/ml)
TIb
coccus aureus Bacillus subtilis GMa
23 ATCC6633
5.33 6.87 213.33 31.05
tested
Fig. 3 Circulat dichroism (CD) spectra of the antimicrobial peptide A20L. Open symbols denote the CD spectra of the peptide in non-denaturating
conditions (KP buffer: pH 7, 50 mM KH2PO4/K2HPO4, 100 mM KCl); solid symbols denote the CD spectra obtained in the presence of an α-helix
inducing solvent TFE (KP buffer: TFE = 1:1, vol/vol)
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peptide, the maximum emission wavelength of trypto-
phan fluorescence was 346.7 nm. The liposomes PC/PG
(7:3, w/w) and the PC/cholesterol (8:1, w/w) were made
to mimic a bacterial and a eukaryotic membrane,
respectively [21]. When the A20L interacted with the
PC/cholesterol liposomes, the maximum emission wave-
length was 341.3 nm, with no obvious blue shift, which
indicates that the A20L peptide did not strongly interact
with the eukaryotic cell membrane. By contrast, when
the A20L interacted with the PC/PG liposomes, the max-
imum emission wavelength of tryptophan fluorescenceFig. 4 Membrane permeabilization assay of the antimicrobial peptide A20L
by NPN uptake in P. aeruginosa ATCC 27853; (b) the effect of A20L on the
β-galactosidase activity (measured from the OD420 nm) from E. coli ML-35 trwas 315.7 nm was accomplished by a shift to blue color,
suggesting that the tryptophan moved into the hydropho-
bic core of the membrane and could strongly interact with
the prokaryotic membrane (Fig. 5a, Table 3).
The water-soluble fluorescent KI quencher was used to
determine the degree of A20L interaction with prokaryotic
and eukaryotic membranes as it is able to reduce the tryp-
tophan fluorescence in the solution (Fig. 5b). The Ksv
value of A20L was lower when added to PC/PG and PC/
Chol liposomes, suggesting that the antimicrobial peptide
A20L is deeper inserted into the prokaryotic membrane,
and, consequently, exhibit stronger interaction specificity. (a) outer membrane permeabilization induced by A20L was detected
inner membrane of E. coli ML-35. Release of cytoplasmic
eated with A20L
Fig. 5 Fluorescence emission spectra and Stern-Volmer plot of A20L
using various liposome models. (a) tryptophan fluorescence emission
spectra of the antimicrobial peptide A20L; (b) Stern-Volmer plots of
the tryptophan fluorescence were obtained by the sequential
addition of the fluorescence quencher KI
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one. These results are consistent with the findings from
MIC, MHC and therapeutic index.
Discussion
Through the use of fusion tags, the toxicity of AMPs to
the host cells can be reduced and their resistance to
intracellular protease degradation increased, thereby
improving their production yield [9, 12]. Fusion tags can
be classified into aggregation-promoting carriers and
solubility-enhancing carriers. The PurF fragment, PaP3.30
and KSI are aggregation-promoting carriers. AMP fused
with aggregation-promoting carriers was shown to be toxicTable 3 Tryptophan fluorescence emission maxima of A20L in
different liposome models
Peptide Liposome model Wavelength (nm) Blue shift (nm) Intensity
A20L
HEPES 346.7 – –
PC/Chol = 8:1 341.3 5.4 36.855
PC/PG = 7:3 315.7 31.0 220.809to host bacterial cells [9, 22]. Thioredoxin (17 kDa) and
glutathione-S-transferase (26 kDa) are solubility-
enhancing carriers, but their large molecular weight indir-
ectly led to low AMP yields [23–25]. The Ub-tag and
SUMO1/2/3/4-tags are small and thus are useful for in-
creasing the proportion of AMPs in fusion proteins,
thereby increasing the yield of AMPs. Currently,
NZ17074, lacticin Q and cecropin AD have been
expressed successfully in E. coli, B. subtilis and P. pastoris
by fusion to the SUMO-tag [26–28]. However, yeast cells
are most commonly reported as the source of SUMO-
tagged fusion peptides [11], while Ub-tagged and human
SUMO-tagged fusion peptides are rarely reported. The
use of a SUMO4-tag and Ub-tag for AMP expression has
not yet been reported previously. Herein, we explored the
expression of A20L tagged with an Ub-tag and
SUMO1/2/3/4-tags to optimize the expression ap-
proach of AMP production. Our findings indicate that
the expression yield was the highest for the Ub-tag
fusion, and the SUMO1-tag was superior to the
SUMO2/3/4-tags. It was interesting to see that all the
human Ub-tag and SUMO1/2/3/4-tags were effective
as fusion tags of AMPs; moreover, the Ub-tag not
only promoted the soluble expression of the AMP,
but also produced a higher yield than the human
SUMO1/2/3/4-tags. The enhancement of both solubil-
ity and yield of the peptide A20L obatained by using
Ub-tag and human SUMO1/2/3/4-tag systems should
enhance the large-scale production of AMPs. Future
work will approach further research to optimize the
fusion tags in order to increase AMPs production.
AMPs can act by inducing membrane injury or intracel-
lular injury [29]. The antibacterial activity of α-helical
AMPs depends on their helicity, positive charge and hydro-
phobicity, etc. After interaction with bacterial cell mem-
branes carrying negative charges, the secondary structure
of AMPs is induced to become α-helical in nature, destroy-
ing the membrane integrity, affecting the electrochemical
potential and ionic balance of the cell membrane, resulting
in leakage of the cell contents, and finally causing bacterial
death [29]. A20L peptides contain hydrophobic and posi-
tively charged amino acids [13]. Circular dichroism experi-
ments have shown that the secondary structure of A20L
adopted an α-helical from a random coil structure after the
interaction with hydrophobic solvents that mimick the
hydrophobic environment of cell membranes. In the bacter-
ial membrane permeabilization experiments, A20L pep-
tide caused rapid damage to the outer membrane of
Gram-negative bacteria, allowing NPN to insert into the
hydrophobic environment, thereby yielding increased fluor-
escence. In addition, after the damage to the bacterial inner
membrane by A20L, β-galactosidase was released from the
cells and reacted with the substrate, ONPG, suggesting that
the bacterial membrane is the target of A20L peptide.
Yi et al. BMC Biotechnology  (2015) 15:69 Page 9 of 10Bacterial and eukaryotic cells exhibit many differ-
ences in the structure and function of their mem-
branes. Prokaryotic cells with a large amount of
negative charges are mainly composed of phosphati-
dylglycerol, cardiolipin, and phosphatidylserine. In
contrast, eukaryotic cells have zwitterionic phospho-
lipids, including phosphatidylethanolamine, phosphat-
idylcholine, cholesterol, and sphingomyelin. Different
membrane lipid compositions play a crucial role in the
specificity of AMPs [30]. In this regard, we prepared
liposomes containing different phospholipids to mimic
prokaryotic and eukaryotic membranes. Tryptophan
fluorescence and KI quenching experiments showed a
stronger interaction between the A20L peptide and
the prokaryotic membrane. The mechanisms used to
describe the interaction of AMPs with bacterial cell
membranes include the “carpet” model, “barrel-stave”
model, “toroidal-pore” model and “aggregate channel”
model [5]. We suggest that the “membrane discrimin-
ation mechanism” could well describe how α-helical
AMPs interact with cell membranes as well as the spe-
cificity of AMPs [16]. The mechanism depends upon
the difference in membrane composition between pro-
karyotic and eukaryotic cells. A20L forms pores/chan-
nels in the hydrophobic core of the eukaryotic bilayer
by bundles of amphipathic α-helices producing an
aqueous pore, it caused the hemolysis of human red
blood cells; the mechanism of A20L with eukaryotic
cells is a “barrel-stave” mechanism. The positive
charge residues of A20L interact with the negatively
charged phospholipid in prokaryotic cells, A20L kills
prokaryotic cells by the “carpet” mechanism.
Conclusions
In conclusion, both the Ub-tag and SUMO1/2/3/4-tags
may be useful for the fusion expression of α-helical
AMPs on an industrial scale. Ub-tag was proved as the
most efficient approach for the expression of α-helical
antimicrobial peptide A20L. Application of fusion tags
for production of AMPs would help to reduce costs and
would be widely applicable for use with a variety of
AMPs. The MIC and MHC values indicated that the
A20L peptide obtained from the fusion expression
showed good antibacterial and low hemolytic activities.
The results from the interaction of the A20L peptide
with liposomes indicated that the membrane discrimin-
ation mechanism may be suitable for explaining the
mechanism of action of α-helical AMPs.
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